-
Subject Areas on Research
-
A Randomized, Double-Blind, Placebo-Controlled Trial of Citicoline for Cocaine Dependence in Bipolar I Disorder.
-
A case of intermittent delirious mania.
-
A controlled study of cellular immune function in affective disorders before and during somatic therapy.
-
A descriptive analysis of minor depression.
-
A follow-up study of post partum illness, 1946-1978.
-
A history of the concept of atypical depression.
-
A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes.
-
A new and timely delusion: the complaint of having AIDS.
-
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
-
A population-based study of KCNH7 p.Arg394His and bipolar spectrum disorder.
-
A prospective study examining the effects of gender and sexual/physical abuse on mood outcomes in patients with co-occurring bipolar I and substance use disorders.
-
A psychometric evaluation of the clinician-rated Quick Inventory of Depressive Symptomatology (QIDS-C16) in patients with bipolar disorder.
-
A randomized, double-blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence.
-
A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.
-
A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.
-
A statistical analysis of the classification of depression in a mixed community and clinical sample.
-
Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms.
-
Adjunctive Maintenance Lamotrigine for Pediatric Bipolar I Disorder: A Placebo-Controlled, Randomized Withdrawal Study.
-
Adjunctive use of olanzapine in mood disorders: five case reports.
-
Affective disorders in five United States communities.
-
Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates.
-
Age-dependent reduction of amygdala volume in bipolar disorder.
-
Alprazolam in bipolar-I depressions.
-
Alprazolam-induced manic reaction.
-
Amygdala activation during emotion processing of neutral faces in children with severe mood dysregulation versus ADHD or bipolar disorder.
-
An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review.
-
An evidence-based medicine strategy for achieving remission in bipolar disorder.
-
Ankyrin-G regulates forebrain connectivity and network synchronization via interaction with GABARAP.
-
Anticipated Benefits of Care (ABC): psychometrics and predictive value in psychiatric disorders.
-
Anticipating DSM-V: opportunities and challenges for cognition and psychosis.
-
Applications of TMS to therapy in psychiatry.
-
Aripiprazole: pharmacology, efficacy, safety and tolerability.
-
Assessing medical students' knowledge in differentiating the diagnosis and treatment of unipolar vs bipolar depression.
-
Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.
-
Associations between residence at birth and mental health disorders: a spatial analysis of retrospective cohort data.
-
Associations between variants near a monoaminergic pathways gene (PHOX2B) and amygdala reactivity: a genome-wide functional imaging study.
-
Atypical depression.
-
Autophosphorylation of CaMKK2 generates autonomous activity that is disrupted by a T85S mutation linked to anxiety and bipolar disorder.
-
Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder.
-
Bariatric surgery in patients with bipolar spectrum disorders: Selection factors, postoperative visit attendance, and weight outcomes.
-
Behavior and emotion modulation deficits in preschoolers at risk for bipolar disorder.
-
Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.
-
Benzodiazepine use and risk of recurrence in bipolar disorder: a STEP-BD report.
-
Bipolar Depression: Pregnancy, Postpartum, and Lactation.
-
Bipolar Disorder and Comorbid Borderline Personality Disorder: Patient Characteristics and Outcomes in US Hospitals.
-
Bipolar Disorder and Dementia: Weighing the Evidence.
-
Bipolar disorder and crossover design.
-
Bipolar disorder is associated with HIV transmission risk behavior among patients in treatment for HIV.
-
Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology.
-
Brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy (ECT) for major depression: efficacy, effectiveness, and cognitive effects.
-
Carbamazepine extended-release capsules: a new treatment option for bipolar I disorder.
-
Case report of treatment of severe mood disorder in an inpatient setting: when less is more.
-
Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine.
-
Catching up on health outcomes: the Texas Medication Algorithm Project.
-
Caudate volume measurement in older adults with bipolar disorder.
-
Characteristics and Correlates of Metabolic Syndrome in Adolescents with Unipolar and Bipolar Depression: Results from a Cross-National Inpatient Case-Control Study.
-
Characterization of a Human-Specific Tandem Repeat Associated with Bipolar Disorder and Schizophrenia.
-
Cherry-picking by trialists and meta-analysts can drive conclusions about intervention efficacy.
-
Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis.
-
Cholinergic-adrenergic hypothesis of mania and depression.
-
Clinical Experience With High-Dosage Pramipexole in Patients With Treatment-Resistant Depressive Episodes in Unipolar and Bipolar Depression.
-
Clinical and economic impact of newer versus older antipsychotic medications in a community mental health center.
-
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
-
Clinical, demographic and social characteristics of psychotic depression.
-
Clinician ratings vs. global ratings of symptom severity: a comparison of symptom measures in the bipolar disorder module, phase II, Texas Medication Algorithm Project.
-
Cognitive burden of anticholinergic medications in psychotic disorders.
-
Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder.
-
Collaborative mental health and primary care for bipolar disorder.
-
Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia.
-
Comments on "Addition of lamotrigine to valproic acid: a successful outcome in a case of rapid-cycling bipolar affective disorder".
-
CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder.
-
Comorbid disorders in patients with bipolar disorder and concomitant substance dependence.
-
Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.
-
Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.
-
Conclusions inconsistent with results with amphetamines and divalproex.
-
Convergent validity of the Timeline Followback for persons with comorbid psychiatric disorders engaged in residential substance use treatment.
-
Convulsive threshold differences in right unilateral and bilateral ECT.
-
Cortical and subcortical white matter abnormalities in adults with remitted first-episode mania revealed by Tract-Based Spatial Statistics.
-
Cortical white matter microstructural abnormalities in bipolar disorder.
-
Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression.
-
Decision model for the acute treatment of mania.
-
Deficiency of Shank2 causes mania-like behavior that responds to mood stabilizers.
-
Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.
-
Demographics, family history, premorbid functioning, developmental characteristics, and course of patients with deteriorated affective disorder.
-
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.
-
Depression and dexamethasone suppression testing in children and adolescents.
-
Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders.
-
Development of a computerized assessment of clinician adherence to a treatment guideline for patients with bipolar disorder.
-
Development of an organic affective syndrome during a hyperbaric diving experiment.
-
Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder.
-
Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression.
-
Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder.
-
Discovery and development of lamotrigine for bipolar disorder: a story of serendipity, clinical observations, risk taking, and persistence.
-
Distinguishing functional from syndromal recovery: implications for clinical care and research.
-
Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial.
-
Do baseline sub-threshold hypomanic symptoms affect acute-phase antidepressant outcome in outpatients with major depressive disorder? Preliminary findings from the randomized CO-MED trial.
-
Does guanfacine trigger mania in children?
-
Does provider adherence to a treatment guideline change clinical outcomes for patients with bipolar disorder? Results from the Texas Medication Algorithm Project.
-
Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
-
Drug rash with eosinophilia and systemic symptoms (DRESS syndrome).
-
Durability of antidepressant response to vagus nerve stimulation (VNS).
-
ECT in bipolar and unipolar depression: differences in speed of response.
-
ECT use in unipolar and bipolar depression.
-
Early physical and sexual abuse associated with an adverse course of bipolar illness.
-
Early physical and sexual abuse associated with an adverse course of bipolar illness.
-
Effect of high-deductible insurance on health care use in bipolar disorder.
-
Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
-
Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review.
-
Efficacy and safety of ketamine in the management of anxiety and anxiety spectrum disorders: a review of the literature.
-
Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group.
-
Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013.
-
Electroconvulsive Therapy in Pregnancy: Safety, Best Practices, and Barriers to Care.
-
Electroconvulsive Treatment Utilization for the Inpatient Management of Severe Manic Episodes of Bipolar Disorder.
-
Electroconvulsive therapy: an update.
-
Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories.
-
Embryonic mania.
-
Evaluation of cognitive function in bipolar disorder using the Brief Assessment of Cognition in Affective Disorders (BAC-A).
-
Evidence-based mental health use of anticonvulsants during pregnancy.
-
Exceptionally high seizure threshold: ECT device limitations.
-
Exercise as a treatment for depression and other psychiatric disorders: a review.
-
Experiences of health care costs among people with employer-sponsored insurance and bipolar disorder.
-
Exploratory investigation of biomarker candidates for suicide in schizophrenia and bipolar disorder.
-
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
-
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
-
Eye-tracking, attention and amphetamine challenge
-
Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.
-
Familial leukoencephalopathy in bipolar disorder.
-
Family history of completed suicide and characteristics of major depressive disorder: a STAR*D (sequenced treatment alternatives to relieve depression) study.
-
Flexible treatment strategies in chronic disease: clinical and research implications.
-
Folate and unipolar depression.
-
Funeral mania in recurrent bipolar affective disorders: reports of three cases.
-
GERI-BD: A Randomized Double-Blind Controlled Trial of Lithium and Divalproex in the Treatment of Mania in Older Patients With Bipolar Disorder.
-
Gabapentin in the treatment of mental illness: the echo chamber of the case series.
-
General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial.
-
Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs.
-
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
-
Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders.
-
Genome-wide Association Meta-analysis of Childhood and Adolescent Internalizing Symptoms.
-
Genome-wide association study of bipolar I disorder in the Han Chinese population.
-
Gray and white matter brain volumes in older adults with bipolar disorder.
-
Guanfacine and secondary mania in children.
-
HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse.
-
Harms are assessed inconsistently and reported inadequately Part 2: nonsystematic adverse events.
-
Harms are assessed inconsistently and reported inadequately part 1: systematic adverse events.
-
High rate of autoimmune thyroiditis in bipolar disorder: lack of association with lithium exposure.
-
High-Deductible Health Plans Paired With Health Savings Accounts Increased Medication Cost Burden Among Individuals With Bipolar Disorder.
-
High-performance liquid chromatography of haloperidol in serum at the concentrations achieved during chronic therapy.
-
Hippocampal volume measurement in older adults with bipolar disorder.
-
How reviews covered the unfolding scientific story of gabapentin for bipolar disorder.
-
Hyperintense MRI lesions in bipolar disorder: A meta-analysis and review.
-
Hyperintense lesions on magnetic resonance images in bipolar disorder.
-
Hypomania following withdrawal of trazodone.
-
Impact of High-Deductible Health Plans on Medication Use Among Individuals With Bipolar Disorder.
-
Impact of obesity on health-related quality of life in schizophrenia and bipolar disorder.
-
Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.
-
Impaired limbic gamma oscillatory synchrony during anxiety-related behavior in a genetic mouse model of bipolar mania.
-
Implementation of the Texas Medication Algorithm Project patient and family education program.
-
Influence of Criminal Justice Involvement and Psychiatric Diagnoses on Treatment Costs Among Adults With Serious Mental Illness.
-
Insight in schizophrenia and mania.
-
Insight is greater in mixed than in pure manic episodes of bipolar I disorder.
-
Integrating Stakeholder Engagement With Claims-Based Research on Health Insurance Design and Bipolar Disorder.
-
Integrating multiple data sources (MUDS) for meta-analysis to improve patient-centered outcomes research: a protocol.
-
International randomized-controlled trial of transcranial Direct Current Stimulation in depression.
-
Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype.
-
Irritability is associated with anxiety and greater severity, but not bipolar spectrum features, in major depressive disorder.
-
Joint analysis of psychiatric disorders increases accuracy of risk prediction for schizophrenia, bipolar disorder, and major depressive disorder.
-
Ketoconazole in bipolar patients with depressive symptoms: a case series and literature review.
-
Key updates in the clinical application of electroconvulsive therapy.
-
Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study.
-
Largest GWAS of PTSD (N=20 070) yields genetic overlap with schizophrenia and sex differences in heritability.
-
Late-life onset bipolar disorder presenting as a case of pseudo-dementia: a case discussion and review of literature.
-
Leukocytosis and hypoalbuminemia in mixed bipolar states: evidence for immune activation.
-
Levocarnitine-induced hypophosphatemia in a hemodialysis patient with acute valproic acid toxicity.
-
Lifetime perturbations of bipolar disorder.
-
Lithium ameliorates nucleus accumbens phase-signaling dysfunction in a genetic mouse model of mania.
-
Lithium for the Maintenance Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Discontinuation Study.
-
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium.
-
Lithium-induced nephrotic syndrome.
-
Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression.
-
Low plasma GABA is a trait-like marker for bipolar illness.
-
Low-dimensional chaos in bipolar disorder?
-
Lower concentration of hippocampal N-acetylaspartate in familial bipolar I disorder.
-
Magnetic resonance imaging abnormalities and psychiatric illness.
-
Mania in Alzheimer's disease.
-
Medical comorbidity in a bipolar outpatient clinical population.
-
Medical comorbidity in bipolar disorder: re-prioritizing unmet needs.
-
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
-
Medication treatment for the severely and persistently mentally ill: the Texas Medication Algorithm Project.
-
Medication-Assisted Treatment for Alcohol-Dependent Adults With Serious Mental Illness and Criminal Justice Involvement: Effects on Treatment Utilization and Outcomes.
-
Membrane biophysical studies of lymphocytes and erythrocytes in manic-depressive illness.
-
Mental health care from the public perspective: the Texas Medication Algorithm Project.
-
Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
-
Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
-
Methodological approaches and magnitude of the clinical unmet need associated with amotivation in mood disorders.
-
Methodological issues in developing new acute treatments for patients with bipolar illness.
-
Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network: a sex-specific phenomenon.
-
Mood variability in adolescents: a study of depressed, nondepressed and comorbid patients.
-
Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method.
-
Multiple outcomes and analyses in clinical trials create challenges for interpretation and research synthesis.
-
Naltrexone in patients with bipolar disorder and alcohol dependence.
-
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
-
National Institute of Mental Health Workshop Report on the Treatment of Bipolar Disorder.
-
Neuroactive steroids are altered in schizophrenia and bipolar disorder: relevance to pathophysiology and therapeutics.
-
Neurocognitive effects of transcranial direct current stimulation (tDCS) in unipolar and bipolar depression: Findings from an international randomized controlled trial.
-
Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.
-
Neuropathology in affective illness.
-
Neuropsychiatric problems after traumatic brain injury: unraveling the silent epidemic.
-
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
-
Neurosteroid Levels in Patients With Bipolar Disorder and a History of Cannabis Use Disorders.
-
New designs for studies of the prophylaxis of bipolar disorder.
-
Nuclear magnetic resonance spectroscopy: new insights into the pathophysiology of mood disorders.
-
Nutrition and Bipolar Depression.
-
Occurrence of subcortical hyperintensities in elderly subjects with mania.
-
Opportunities for selective reporting of harms in randomized clinical trials: Selection criteria for non-systematic adverse events.
-
Parental relationships and behavioral approach system dysregulation in young adults with bipolar disorder.
-
Patterns of justice involvement among adults with schizophrenia and bipolar disorder: key risk factors.
-
Patterns of pharmacotherapy and treatment response in elderly adults with bipolar disorder.
-
Pediatric Bipolar Disorder: Onset, Risk Factors, and Protective Factors.
-
Performance of a weight-related measure of Quality of Life in a psychiatric sample.
-
Personality assessment inventory internalizing and externalizing structure in veterans with posttraumatic stress disorder: associations with aggression.
-
Pharmacotherapy of bipolar disorder in old age: review and recommendations.
-
Plasma GABA predicts acute response to divalproex in mania.
-
Platelet monoamine oxidase activity and the classification of depression.
-
Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
-
Possible bipolar nature of irritability in major depressive disorder.
-
Practitioner review: the assessment of bipolar disorder in children and adolescents.
-
Prevalence of HIV infection in a general psychiatric outpatient population.
-
Prevalence of antithyroid antibodies in mood disorders
-
Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study.
-
Prioritization of research addressing antipsychotics for adolescents and young adults with bipolar disorder.
-
Prolactin-related and metabolic adverse effects of atypical antipsychotic agents.
-
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
-
Psychiatric and medical comorbidities of bipolar disorder.
-
Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness.
-
Psychotherapeutic Treatment of Bipolar Depression.
-
Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.
-
REM latency concordance in depressed family members.
-
Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
-
Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers.
-
Recurrent premenstrual decline in serum lithium concentration: clinical correlates and treatment implications.
-
Reduced REM latency predicts response to tricyclic medication in depressed outpatients.
-
Reduced white matter integrity and verbal fluency impairment in young adults with bipolar disorder: a diffusion tensor imaging study.
-
Reducing barriers to completing psychiatric advance directives.
-
Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study.
-
Relation of serum valproate concentration to response in mania.
-
Relationships among the TRH, REM latency, and dexamethasone suppression tests: preliminary findings.
-
Religiosity, depression, and quality of life in bipolar disorder: a two-year prospective study.
-
Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial.
-
Response, remission, and recovery in bipolar disorders: what are the realistic treatment goals?
-
Resting-state brain function in schizophrenia and psychotic bipolar probands and their first-degree relatives.
-
Risk factors for early unplanned readmission in patients with bipolar disorder: A retrospective observational study.
-
Role of treatment alliance in the clinical management of bipolar disorder: stronger alliances prospectively predict fewer manic symptoms.
-
Scopolamine sleep treatment in private practise.
-
Second-Generation Antipsychotics in Management of Acute Pediatric Bipolar Depression: A Systematic Review and Meta-analysis.
-
Seizure threshold in electroconvulsive therapy (ECT) II. The anticonvulsant effect of ECT.
-
Seizure threshold in electroconvulsive therapy: I. Initial seizure threshold.
-
Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders.
-
Sleep disturbance in euthymic bipolar patients.
-
Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia.
-
Sleep impairment, mood symptoms, and psychosocial functioning in adolescent bipolar disorder.
-
Sleep parameters in bipolar I, bipolar II, and unipolar depressions.
-
Smoking and psychosis in patients with bipolar I disorder.
-
Social support in elderly patients with bipolar disorder.
-
Social support in late life mania: GERI-BD.
-
Stressful life events in older bipolar patients.
-
Structural changes in the brain of patients with bipolar affective disorder by MRI: a review of the literature.
-
Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.
-
Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions.
-
Study design and methodology for a multicentre, randomised controlled trial of transcranial direct current stimulation as a treatment for unipolar and bipolar depression.
-
Subcortical hyperintensities on brain magnetic resonance imaging: a comparison of normal and bipolar subjects.
-
Subtypes of mania determined by grade of membership analysis.
-
Suicidal ideation and attempts in unipolar versus bipolar depression: analysis of 131,740 adolescent inpatients nationwide.
-
Suicide Behaviors in Bipolar Disorder: A Review and Update for the Clinician.
-
Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics.
-
Suicide in pregnancy.
-
Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy.
-
Targeting Treatments to Improve Cognitive Function in Mood Disorder: Suggestions From Trials Using Erythropoietin.
-
Temporal lobe volume in bipolar disorder: relationship with diagnosis and antipsychotic medication use.
-
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
-
Texas Medication Algorithm Project, phase 3 (TMAP-3): rationale and study design.
-
Texas Medication Algorithm Project: definitions, rationale, and methods to develop medication algorithms.
-
Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder.
-
The Brief Assessment of Cognition In Affective Disorders (BAC-A):performance of patients with bipolar depression and healthy controls.
-
The Challenge of Bipolar Depression in the 21st Century.
-
The Inventory for Depressive Symptomatology (IDS): preliminary findings.
-
The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) in public sector patients with mood disorders: a psychometric evaluation.
-
The MATRICS consensus cognitive battery in patients with bipolar I disorder.
-
The Stanley Foundation Bipolar Network. 2. Preliminary summary of demographics, course of illness and response to novel treatments.
-
The Stanley Foundation Bipolar Network. I. Rationale and methods.
-
The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology.
-
The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients.
-
The Texas Medication Algorithm Project Patient and Family Education Program: a consumer-guided initiative.
-
The Use of Antidepressants in Bipolar Depression.
-
The dexamethasone suppression test and quantitative cerebral anatomy in depression.
-
The dexamethasone suppression test in borderline personality disorder.
-
The dexamethasone suppression test in patients with mood disorders.
-
The effect of surgery on intraocular pressure fluctuations with electroconvulsive therapy in a patient with severe glaucoma.
-
The effects of vagus nerve stimulation on sleep EEG in depression: a preliminary report.
-
The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness.
-
The highs and lows of amygdala reactivity in bipolar disorders.
-
The impact of treatment-resistant depression on health care utilization and costs.
-
The importance of nicotinic acetylcholine receptors in schizophrenia, bipolar disorder and Tourette's syndrome.
-
The intricate link between violence and mental disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
-
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response.
-
The need for paediatric registries to assess long-term brain effects of psychotropic medications: The case of bipolar disorder.
-
The quick inventory of depressive symptomatology (clinician and self-report versions) in patients with bipolar disorder.
-
The relationship of bipolar disorder lifetime duration and vascular burden to cognition in older adults.
-
The relationship of manic episodes and drug abuse to sexual risk behavior in patients with co-occurring bipolar and substance use disorders: a 15-month prospective analysis.
-
The thyrotropin-releasing hormone stimulation test: a methodological study.
-
The use of antiepileptic drugs in bipolar disorders: a review based on evidence from controlled trials.
-
Tiagabine in treatment refractory bipolar disorder: a clinical case series.
-
Toward a rational pharmacotherapy of depression.
-
Toward an understanding of bipolar disorder and its origin.
-
Transcriptome analysis of cortical tissue reveals shared sets of downregulated genes in autism and schizophrenia.
-
Treatment algorithm use to optimize management of symptomatic patients with a history of mania.
-
Treatment participation and medication adherence: effects on criminal justice costs of persons with mental illness.
-
Unipolar depression does not moderate responses to the Sweet Taste Test.
-
Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
-
Urinary excretion of biopterin and neopterin in psychiatric disorders.
-
Vagus Nerve Stimulation in Patients Receiving Maintenance Therapy With Electroconvulsive Therapy: A Series of 10 Cases.
-
Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
-
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
-
Validation of the prospective NIMH-Life-Chart Method (NIMH-LCM-p) for longitudinal assessment of bipolar illness.
-
Volumetric brain imaging studies in the elderly with mood disorders.
-
Weight change in depression.
-
What are the new treatments for bipolar disorder?
-
When the Provider Becomes the Patient.
-
White matter abnormalities in bipolar disorder: insights from diffusion tensor imaging studies.
-
White matter hyperintensity on magnetic resonance imaging: clinical and neuroanatomic correlates in the depressed elderly.
-
Who are the new users of antipsychotic medications?
-
Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
-
Ziprasidone-associated mania: a case series and review of the mechanism.
-
miR-149 and miR-29c as candidates for bipolar disorder biomarkers.
-
Keywords of People